U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07594912) titled 'Teprotumumab N01 Versus Methylprednisolone After Urgent Orbital Decompression for Dysthyroid Optic Neuropathy' on May 05.
Brief Summary: This study aims to evaluate the efficacy and safety of sequential Teprotumumab N01 compared with intravenous methylprednisolone (IVMP) after urgent orbital decompression in patients with dysthyroid optic neuropathy (DON).
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Thyroid Eye Disease, TED
Graves Ophthalmopathy
Optic Neuropathy
Intervention:
DRUG: Teprotumumab N01
Teprotumumab N01 will be administered intravenously after urgent orbital decompression. The first infusion ...